MicroRNA-145 function as a cell growth repressor by directly targeting c-Myc in human ovarian cancer

Wenjing Zhang1, Qian Wang, Minglian Yu

  • 1Department of Gynecology and Obstetrics, The Military General Hospital of Beijing PLA, No. 5 Nan Men Cang, Dongcheng District, Beijing 100700, PR China. wanghuibjing@sina.cn.

Insights

MicroRNA-145 (miR-145) is down-regulated in ovarian cancer. Restoring miR-145 inhibits cancer cell growth and promotes cell death by targeting c-Myc, suggesting its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ovarian cancer is a significant health concern with limited effective treatments.
  • MicroRNA-145 (miR-145) has been observed to be downregulated in ovarian cancer tissues.
  • Understanding the specific roles of miR-145 in epithelial ovarian cancer (EOC) is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the functional role of miR-145 in regulating the biological behavior of epithelial ovarian cancer (EOC) cells.
  • To determine the molecular mechanism by which miR-145 exerts its effects on EOC cells.
  • To evaluate the potential of miR-145 as a therapeutic target for ovarian cancer.

Main Methods:

  • Transfection of miR-145 mimics into OVCAR-3 and SKOV-3 EOC cell lines.
  • Cell proliferation assays (e.g., MTT assay).
  • Apoptosis assays (e.g., flow cytometry).
  • Western blotting to assess protein expression levels.
  • Luciferase reporter assays to confirm direct targeting of c-Myc.
  • Cell cycle analysis.

Main Results:

  • Up-regulation of miR-145 significantly inhibited cell proliferation and induced apoptosis in OVCAR-3 and SKOV-3 cells.
  • miR-145 was found to directly target the 3'-untranslated region (3'-UTR) of c-Myc mRNA.
  • Ectopic expression of c-Myc partially rescued the inhibitory effect of miR-145 on cell proliferation.
  • miR-145 transfection led to a reduction in the S phase cell population, which was reversed by c-Myc restoration.

Conclusions:

  • miR-145 functions as a tumor suppressor in epithelial ovarian cancer.
  • The anti-proliferative and pro-apoptotic effects of miR-145 are mediated through direct targeting of c-Myc.
  • miR-145 represents a promising molecular target for the development of novel therapeutic interventions for ovarian cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...